A European Medicines Agency (EMA) committee said on Friday it has started a review of decongestant medicines for cold and flu that contain the ingredient pseudoephedrine following safety concerns.
The EMA said the review was due to reports of conditions affecting blood vessels in the brain in some patients who took pseudoephedrine-containing medicines.
Pseudoephedrine is a drug that is used alone or in combination with other medicines to treat a blocked nose due to cold, flu or allergy.
Makers of pseudoephedrine-containing drugs include Reckitt Benckiser, McNeil Products Ltd and Organon & Co.
(Reporting by Sriparna Roy in Bengaluru; editing by Shounak Dasgupta)
Topics Europe
Was this article valuable?
Here are more articles you may enjoy.
Judge Nixes Uber’s RICO Suit Alleging NY Lawyers, Doctors Conspired on Auto Claims 
Should Parents Be Responsible for Kids Getting Hurt and Killed on E-Bikes? 
Picasso Etching Stolen From Wisconsin Art Gallery Found in Vacant Apartment 
Lawsuit Alleges TWIA Fraudulently Reduced Claim Estimates From Hurricane Beryl 
